About Omics
Omics Global Solutions (OGS) was born as a company whose objective is to be the platform for the development and commercialization of products related to OMICS sciences (proteomics, among others.) Associated with innovative projects that positively impact the lives of patients and medical professionals.
Located in Puerto Rico (USA), its first milestone is the development, manufacture and commercialization of a test based on recently discovered biomarkers, to identify the risk of developing Diabetic Nephropathy. INNOVATIO ND2™
MISSION
Focused on biotechnology, our mission is to develop and commercialize clinical prognostic products based on novel scientific models, addressing the unmet needs of physicians and patients. Having as main strength; an extensive commercial experience in Latin America and direct ties with the United States, we remain committed to high quality standards, bringing science to the community.
VISION
To be a commercially successful company in the introduction of innovative diagnostic products that help health professionals in the implementation of early therapeutic approaches for patients that allow saving lives, ranking among the fastest growing biotechnology companies by 2030 in LATAM and the United States.
Products
Our portfolio is focused on the development of ELISA assays and other platforms, designed to provide diagnosis and prognosis of various diseases based on novel Biomarkers.
The discovery and development of antibodies has created intense interest in identifying prognostic markers and predictive markers.
